haem_001:
  morphology: ACUTE_MYELOID_LEUKAEMIA
  descriptive_name: AML
  biomarker_profile: "NPM1 mutated. FLT3-ITD positive with allelic ratio 0.65."

haem_002:
  morphology: CHRONIC_MYELOID_LEUKAEMIA
  descriptive_name: Chronic myelogenous leukemia
  biomarker_profile: "BCR-ABL1 fusion detected by RT-PCR, p210 transcript type. Quantitative PCR shows BCR-ABL1/ABL1 ratio of 45% on the International Scale."

haem_003:
  morphology: ACUTE_LYMPHOBLASTIC_LEUKAEMIA
  descriptive_name: B-ALL
  biomarker_profile: "No targetable mutations identified."

haem_004:
  morphology: NON_HODGKIN_LYMPHOMA
  descriptive_name: Diffuse large B-cell lymphoma
  biomarker_profile: "MYC rearrangement positive by FISH (85% of cells). BCL2 translocation detected. BCL6 rearrangement negative. TP53 wild-type by NGS. Double-hit lymphoma confirmed."

haem_005:
  morphology: MULTIPLE_MYELOMA
  descriptive_name: MM
  biomarker_profile: "TP53 deletion identified by FISH in 62% of plasma cells."

haem_006:
  morphology: ACUTE_MYELOID_LEUKAEMIA
  descriptive_name: Acute myeloid leukemia
  biomarker_profile: "FLT3-TKD mutation detected (D835Y). NPM1 wild-type. TP53 mutation identified: c.818G>A (p.R273H)."

haem_007:
  morphology: CHRONIC_LYMPHOCYTIC_LEUKAEMIA
  descriptive_name: CLL
  biomarker_profile: "TP53 mut detected - p.Y220C"

haem_008:
  morphology: HODGKIN_LYMPHOMA
  descriptive_name: Classical Hodgkin lymphoma
  biomarker_profile: "Comprehensive genomic profiling performed - no clinically actionable alterations identified."

haem_009:
  morphology: ACUTE_LYMPHOBLASTIC_LEUKAEMIA
  descriptive_name: Philadelphia-positive ALL
  biomarker_profile: "BCR-ABL1 fusion positive (p190 isoform) by RT-PCR. TP53 mutation analysis negative."

haem_010:
  morphology: NON_HODGKIN_LYMPHOMA
  descriptive_name: Follicular lymphoma
  biomarker_profile: "BCL2 rearrangement detected by FISH. No MYC rearrangement. TP53 wild type."

haem_011:
  morphology: MYELODYSPLASTIC
  descriptive_name: MDS
  biomarker_profile: "TP53 mutation identified: c.524G>A (p.R175H) with VAF of 35%."

haem_012:
  morphology: ACUTE_MYELOID_LEUKAEMIA
  descriptive_name: AML with mutated NPM1
  biomarker_profile: "NPM1 type A mutation positive. FLT3-ITD negative. FLT3-TKD negative."

haem_013:
  morphology: CHRONIC_MYELOID_LEUKAEMIA
  descriptive_name: CML in chronic phase
  biomarker_profile: "BCR::ABL1 detected"

haem_014:
  morphology: MULTIPLE_MYELOMA
  descriptive_name: Multiple myeloma
  biomarker_profile: "No actionable mutations detected on targeted sequencing panel."

haem_015:
  morphology: LEUKAEMIA_OTHER
  descriptive_name: Hairy cell leukemia
  biomarker_profile: "JAK2 V617F mutation negative. TP53 analysis: wild-type."

haem_016:
  morphology: ACUTE_LYMPHOBLASTIC_LEUKAEMIA
  descriptive_name: T-cell ALL
  biomarker_profile: "BCR-ABL1 negative. TP53 deletion detected by FISH in 73% of cells."

haem_017:
  morphology: NON_HODGKIN_LYMPHOMA
  descriptive_name: DLBCL, NOS
  biomarker_profile: "BCL2 expression positive by IHC (>50%). MYC expression 40%. TP53 mutation p.R248W detected. Double expressor phenotype."

haem_018:
  morphology: ACUTE_MYELOID_LEUKAEMIA
  descriptive_name: Acute myelogenous leukemia
  biomarker_profile: "FLT3 internal tandem duplication detected with high allelic ratio (0.92). NPM1 mutation positive (type B). TP53 wild-type."

haem_019:
  morphology: CHRONIC_LYMPHOCYTIC_LEUKAEMIA
  descriptive_name: Small lymphocytic lymphoma
  biomarker_profile: "TP53 disruption present - del(17p) in 45% cells"

haem_020:
  morphology: HODGKIN_LYMPHOMA
  descriptive_name: Nodular sclerosis Hodgkin
  biomarker_profile: "Molecular testing not performed."

haem_021:
  morphology: MYELODYSPLASTIC
  descriptive_name: Myelodysplastic syndrome with excess blasts
  biomarker_profile: "TP53 mutation c.733G>A (p.G245S) detected by next-generation sequencing with variant allele frequency of 28%."

haem_022:
  morphology: ACUTE_MYELOID_LEUKAEMIA
  descriptive_name: AML
  biomarker_profile: "NPM1-"

haem_023:
  morphology: CHRONIC_MYELOID_LEUKAEMIA
  descriptive_name: Ph+ CML
  biomarker_profile: "BCR-ABL1 p210 positive. Baseline BCR-ABL1 IS: 89.5%."

haem_024:
  morphology: NON_HODGKIN_LYMPHOMA
  descriptive_name: Mantle cell lymphoma
  biomarker_profile: "TP53 mutation analysis: c.742C>T (p.R248W). MYC rearrangement absent."

haem_025:
  morphology: MULTIPLE_MYELOMA
  descriptive_name: Plasma cell myeloma
  biomarker_profile: "Standard FISH panel negative including TP53."

haem_026:
  morphology: ACUTE_LYMPHOBLASTIC_LEUKAEMIA
  descriptive_name: Pre-B acute lymphoblastic leukemia
  biomarker_profile: "Philadelphia chromosome detected by karyotype. BCR-ABL1 p190 transcript confirmed. TP53 intact."

haem_027:
  morphology: LEUKAEMIA_OTHER
  descriptive_name: CMML
  biomarker_profile: "JAK2 V617F positive with allele burden of 12%. TP53 sequencing: no mutations detected."

haem_028:
  morphology: ACUTE_MYELOID_LEUKAEMIA
  descriptive_name: AML with FLT3 mutation
  biomarker_profile: "FLT3-ITD positive (AR: 0.45), NPM1 mutated (type D), TP53 wt"

haem_029:
  morphology: NON_HODGKIN_LYMPHOMA
  descriptive_name: High-grade B-cell lymphoma
  biomarker_profile: "MYC rearrangement positive. BCL2 rearrangement positive. BCL6 rearrangement positive. Triple-hit lymphoma."

haem_030:
  morphology: CHRONIC_LYMPHOCYTIC_LEUKAEMIA
  descriptive_name: CLL/SLL
  biomarker_profile: "No TP53 aberrations detected by FISH or sequencing."

haem_031:
  morphology: HODGKIN_LYMPHOMA
  descriptive_name: Hodgkin disease
  biomarker_profile: "No biomarker testing indicated."

haem_032:
  morphology: MULTIPLE_MYELOMA
  descriptive_name: IgG kappa myeloma
  biomarker_profile: "TP53 deletion absent. Hyperdiploidy detected by FISH."

haem_033:
  morphology: ACUTE_MYELOID_LEUKAEMIA
  descriptive_name: Secondary AML
  biomarker_profile: "Complex molecular profile: NPM1 negative, FLT3-ITD negative, TP53 p.R273C mutation detected with VAF 67%."

haem_034:
  morphology: MYELODYSPLASTIC
  descriptive_name: MDS-EB2
  biomarker_profile: "TP53 p.Y220C"

haem_035:
  morphology: ACUTE_LYMPHOBLASTIC_LEUKAEMIA
  descriptive_name: B-lymphoblastic leukemia
  biomarker_profile: "BCR-ABL1 fusion negative by FISH and PCR. No TP53 alterations."

haem_036:
  morphology: CHRONIC_MYELOID_LEUKAEMIA
  descriptive_name: Chronic myeloid leukemia
  biomarker_profile: "Major molecular response achieved. BCR-ABL1 IS: 0.08%."

haem_037:
  morphology: NON_HODGKIN_LYMPHOMA
  descriptive_name: Burkitt lymphoma
  biomarker_profile: "MYC rearrangement confirmed by FISH (95% positive cells). BCL2 and BCL6 negative. TP53 mutation detected: p.R175H."

haem_038:
  morphology: LEUKAEMIA_OTHER
  descriptive_name: Polycythemia vera
  biomarker_profile: "JAK2 V617F mutation positive (allele burden 78%)."

haem_039:
  morphology: ACUTE_MYELOID_LEUKAEMIA
  descriptive_name: Acute myeloid leukemia, NOS
  biomarker_profile: "Comprehensive panel: NPM1 wild-type, FLT3 wild-type, TP53 wild-type."

haem_040:
  morphology: CHRONIC_LYMPHOCYTIC_LEUKAEMIA
  descriptive_name: Chronic lymphocytic leukemia
  biomarker_profile: "TP53 mutation p.R282W identified. IGHV unmutated."

haem_041:
  morphology: MULTIPLE_MYELOMA
  descriptive_name: Relapsed MM
  biomarker_profile: "TP53 del(17p) detected in 89% of cells by FISH. High-risk disease."

haem_042:
  morphology: NON_HODGKIN_LYMPHOMA
  descriptive_name: Marginal zone lymphoma
  biomarker_profile: "No MYC, BCL2, or TP53 abnormalities detected."

haem_043:
  morphology: ACUTE_LYMPHOBLASTIC_LEUKAEMIA
  descriptive_name: Ph-like ALL
  biomarker_profile: "BCR-ABL1 negative. TP53 mutation analysis pending."

haem_044:
  morphology: HODGKIN_LYMPHOMA
  descriptive_name: Lymphocyte-rich classical HL
  biomarker_profile: "Biomarker assessment not clinically indicated."

haem_045:
  morphology: ACUTE_MYELOID_LEUKAEMIA
  descriptive_name: AML-MRC
  biomarker_profile: "FLT3-ITD detected with low allelic ratio (0.12). NPM1 mutation absent. TP53 mutation p.G245S present."

haem_046:
  morphology: MYELODYSPLASTIC
  descriptive_name: Hypoplastic MDS
  biomarker_profile: "TP53 wild-type by NGS"

haem_047:
  morphology: CHRONIC_MYELOID_LEUKAEMIA
  descriptive_name: CML, accelerated phase
  biomarker_profile: "BCR-ABL1 detected. Additional mutations: none identified. BCR-ABL1/ABL1: 15.3% IS."

haem_048:
  morphology: NON_HODGKIN_LYMPHOMA
  descriptive_name: Primary mediastinal B-cell lymphoma
  biomarker_profile: "MYC non-rearranged. BCL2 and BCL6 testing negative."

haem_049:
  morphology: LEUKAEMIA_OTHER
  descriptive_name: Essential thrombocythemia
  biomarker_profile: "JAK2 wild-type. TP53 not tested."

haem_050:
  morphology: ACUTE_MYELOID_LEUKAEMIA
  descriptive_name: Core binding factor AML
  biomarker_profile: "NPM1 mutation negative as expected. FLT3 analysis negative."

haem_051:
  morphology: MULTIPLE_MYELOMA
  descriptive_name: Light chain myeloma
  biomarker_profile: "TP53 mutation c.844C>T (p.R282W) detected."

haem_052:
  morphology: ACUTE_LYMPHOBLASTIC_LEUKAEMIA
  descriptive_name: Early T-cell precursor ALL
  biomarker_profile: "No BCR-ABL1 fusion. TP53 wild-type."

haem_053:
  morphology: CHRONIC_LYMPHOCYTIC_LEUKAEMIA
  descriptive_name: CLL
  biomarker_profile: "TP53 disrupted"

haem_054:
  morphology: NON_HODGKIN_LYMPHOMA
  descriptive_name: Transformed follicular lymphoma
  biomarker_profile: "MYC rearrangement acquired. BCL2 rearrangement present (pre-existing). TP53 p.Y234C mutation detected."

haem_055:
  morphology: HODGKIN_LYMPHOMA
  descriptive_name: Mixed cellularity Hodgkin lymphoma
  biomarker_profile: "No molecular studies performed."

haem_056:
  morphology: ACUTE_MYELOID_LEUKAEMIA
  descriptive_name: Therapy-related AML
  biomarker_profile: "NPM1 wild-type. FLT3-ITD absent. FLT3-TKD absent. TP53 p.R175H mutation with VAF 72%."

haem_057:
  morphology: MYELODYSPLASTIC
  descriptive_name: MDS with ring sideroblasts
  biomarker_profile: "TP53 intact. SF3B1 mutation detected."

haem_058:
  morphology: CHRONIC_MYELOID_LEUKAEMIA
  descriptive_name: BCR-ABL positive CML
  biomarker_profile: "e14a2 transcript detected. Quantitative: 0.003% IS (deep molecular response)."

haem_059:
  morphology: LEUKAEMIA_OTHER
  descriptive_name: Primary myelofibrosis
  biomarker_profile: "JAK2 V617F positive, allele frequency 45%. TP53 sequencing negative."

haem_060:
  morphology: NON_HODGKIN_LYMPHOMA
  descriptive_name: Anaplastic large cell lymphoma
  biomarker_profile: "ALK-negative. TP53 mutation detected: c.743G>A."

haem_061:
  morphology: MULTIPLE_MYELOMA
  descriptive_name: PCM
  biomarker_profile: "No TP53 deletion or mutation identified."

haem_062:
  morphology: ACUTE_MYELOID_LEUKAEMIA
  descriptive_name: AML with normal karyotype
  biomarker_profile: "NPM1 mutation positive (4bp insertion). FLT3-ITD positive with high allelic ratio (1.2)."

haem_063:
  morphology: ACUTE_LYMPHOBLASTIC_LEUKAEMIA
  descriptive_name: Mixed phenotype acute leukemia
  biomarker_profile: "BCR-ABL1 not detected. TP53 analysis: no mutations."

haem_064:
  morphology: CHRONIC_LYMPHOCYTIC_LEUKAEMIA
  descriptive_name: Richter transformation
  biomarker_profile: "TP53 mutation p.R248Q detected. Complex karyotype present."

haem_065:
  morphology: NON_HODGKIN_LYMPHOMA
  descriptive_name: Extranodal NK/T-cell lymphoma
  biomarker_profile: "TP53 p.R175H mutation identified."

haem_066:
  morphology: HODGKIN_LYMPHOMA
  descriptive_name: HL
  biomarker_profile: "Not tested"

haem_067:
  morphology: ACUTE_MYELOID_LEUKAEMIA
  descriptive_name: Acute monocytic leukemia
  biomarker_profile: "NPM1 mutation detected (type A). FLT3 wild-type for both ITD and TKD."

haem_068:
  morphology: MYELODYSPLASTIC
  descriptive_name: MDS, unclassifiable
  biomarker_profile: "TP53 mutation analysis: p.C238Y detected with 18% VAF."

haem_069:
  morphology: CHRONIC_MYELOID_LEUKAEMIA
  descriptive_name: Ph chromosome positive CML
  biomarker_profile: "BCR-ABL1 major transcript. Current level: undetectable (MR4.5)."

haem_070:
  morphology: MULTIPLE_MYELOMA
  descriptive_name: Smoldering myeloma
  biomarker_profile: "FISH panel including TP53: all negative."

haem_071:
  morphology: LEUKAEMIA_OTHER
  descriptive_name: Myeloproliferative neoplasm, NOS
  biomarker_profile: "JAK2 V617F heterozygous mutation. TP53: no mutations."

haem_072:
  morphology: NON_HODGKIN_LYMPHOMA
  descriptive_name: Peripheral T-cell lymphoma
  biomarker_profile: "TP53 mutation absent. Limited targetable alterations."

haem_073:
  morphology: ACUTE_LYMPHOBLASTIC_LEUKAEMIA
  descriptive_name: B-ALL with hyperdiploidy
  biomarker_profile: "BCR-ABL negative. No TP53 abnormalities."

haem_074:
  morphology: ACUTE_MYELOID_LEUKAEMIA
  descriptive_name: AML-M4
  biomarker_profile: "FLT3-ITD neg, NPM1 neg, TP53 neg"

haem_075:
  morphology: CHRONIC_LYMPHOCYTIC_LEUKAEMIA
  descriptive_name: B-CLL
  biomarker_profile: "TP53 mutation p.R273H. Del(17p) present in 67% cells."

haem_076:
  morphology: NON_HODGKIN_LYMPHOMA
  descriptive_name: Lymphoplasmacytic lymphoma
  biomarker_profile: "MYD88 L265P mutation detected. No MYC or BCL2 rearrangements."

haem_077:
  morphology: HODGKIN_LYMPHOMA
  descriptive_name: Advanced stage Hodgkin
  biomarker_profile: "Molecular profiling not routinely performed."

haem_078:
  morphology: MULTIPLE_MYELOMA
  descriptive_name: Newly diagnosed MM
  biomarker_profile: "TP53 deletion by FISH: not detected. t(11;14) present."

haem_079:
  morphology: ACUTE_MYELOID_LEUKAEMIA
  descriptive_name: Favorable risk AML
  biomarker_profile: "NPM1 mutated without FLT3-ITD. TP53 wild-type."

haem_080:
  morphology: MYELODYSPLASTIC
  descriptive_name: Therapy-related MDS
  biomarker_profile: "TP53 biallelic inactivation: p.R248W mutation + del(17p)."

haem_081:
  morphology: CHRONIC_MYELOID_LEUKAEMIA
  descriptive_name: Chronic phase CML
  biomarker_profile: "BCR-ABL1 b3a2 fusion. Baseline transcript level: 76% IS."

haem_082:
  morphology: ACUTE_LYMPHOBLASTIC_LEUKAEMIA
  descriptive_name: Infant ALL
  biomarker_profile: "KMT2A rearranged. BCR-ABL1 negative."

haem_083:
  morphology: LEUKAEMIA_OTHER
  descriptive_name: Systemic mastocytosis
  biomarker_profile: "KIT D816V mutation positive. JAK2 negative."

haem_084:
  morphology: NON_HODGKIN_LYMPHOMA
  descriptive_name: Primary CNS lymphoma
  biomarker_profile: "MYC expression elevated. BCL2 co-expression present. TP53 wild-type."

haem_085:
  morphology: ACUTE_MYELOID_LEUKAEMIA
  descriptive_name: Elderly AML
  biomarker_profile: "NPM1 mutation absent. FLT3-ITD absent. TP53 mutation p.Y234C present."

haem_086:
  morphology: CHRONIC_LYMPHOCYTIC_LEUKAEMIA
  descriptive_name: Relapsed CLL
  biomarker_profile: "TP53 pathway intact at diagnosis, now shows p.G245S mutation."

haem_087:
  morphology: MULTIPLE_MYELOMA
  descriptive_name: IgA myeloma
  biomarker_profile: "High-risk FISH: TP53 deletion present (82% cells)."

haem_088:
  morphology: NON_HODGKIN_LYMPHOMA
  descriptive_name: Gray zone lymphoma
  biomarker_profile: "MYC rearrangement present. BCL2 and BCL6 non-rearranged. TP53 mutation: p.R273C."

haem_089:
  morphology: HODGKIN_LYMPHOMA
  descriptive_name: Relapsed Hodgkin lymphoma
  biomarker_profile: "No actionable targets identified on extended panel."

haem_090:
  morphology: ACUTE_MYELOID_LEUKAEMIA
  descriptive_name: AML with inv(16)
  biomarker_profile: "CBFB-MYH11 fusion confirmed. FLT3 and NPM1 not tested (not indicated)."

haem_091:
  morphology: MYELODYSPLASTIC
  descriptive_name: Low-risk MDS
  biomarker_profile: "TP53: wild-type"

haem_092:
  morphology: CHRONIC_MYELOID_LEUKAEMIA
  descriptive_name: Blast crisis CML
  biomarker_profile: "BCR-ABL1 present with T315I mutation. Multiple additional mutations detected."

haem_093:
  morphology: ACUTE_LYMPHOBLASTIC_LEUKAEMIA
  descriptive_name: ETP-ALL
  biomarker_profile: "Negative for BCR-ABL1. Complex genomic profile. TP53 intact."

haem_094:
  morphology: LEUKAEMIA_OTHER
  descriptive_name: MPN-U
  biomarker_profile: "JAK2, CALR, MPL all negative (triple-negative MPN)."

haem_095:
  morphology: NON_HODGKIN_LYMPHOMA
  descriptive_name: Splenic marginal zone lymphoma
  biomarker_profile: "No high-grade features. MYC, BCL2, TP53 all negative."

haem_096:
  morphology: MULTIPLE_MYELOMA
  descriptive_name: Extramedullary myeloma
  biomarker_profile: "TP53 mutation p.R175H detected in plasmacytoma tissue."

haem_097:
  morphology: ACUTE_MYELOID_LEUKAEMIA
  descriptive_name: Relapsed/refractory AML
  biomarker_profile: "FLT3-ITD acquired at relapse (AR: 0.88). NPM1 mutation persists. TP53 p.Y220C emerging clone."

haem_098:
  morphology: CHRONIC_LYMPHOCYTIC_LEUKAEMIA
  descriptive_name: CLL with del(17p)
  biomarker_profile: "TP53 deletion confirmed. Sequencing shows p.R248W mutation on remaining allele."

haem_099:
  morphology: NON_HODGKIN_LYMPHOMA
  descriptive_name: Transformed DLBCL
  biomarker_profile: "Double-hit with MYC and BCL2 translocations. TP53 mutation p.R175H. Aggressive phenotype."

haem_100:
  morphology: HODGKIN_LYMPHOMA
  descriptive_name: Nodular lymphocyte-predominant HL
  biomarker_profile: "Distinct entity - biomarker testing not standard."

haem_101:
  morphology: ACUTE_MYELOID_LEUKAEMIA
  descriptive_name: APL
  biomarker_profile: "PML-RARA fusion confirmed. FLT3-ITD present (common in APL). NPM1 not tested."

haem_102:
  morphology: MYELODYSPLASTIC
  descriptive_name: High-risk MDS
  biomarker_profile: "Complex karyotype with TP53 mutation p.C242F (VAF 91%)."

haem_103:
  morphology: CHRONIC_MYELOID_LEUKAEMIA
  descriptive_name: Atypical CML
  biomarker_profile: "BCR-ABL1 negative (defining feature). SETBP1 mutation detected."

haem_104:
  morphology: ACUTE_LYMPHOBLASTIC_LEUKAEMIA
  descriptive_name: B-cell ALL
  biomarker_profile: "t(9;22) positive. BCR-ABL1 p210 isoform. TP53 co-mutation p.R273H."

haem_105:
  morphology: MULTIPLE_MYELOMA
  descriptive_name: Oligosecretory myeloma
  biomarker_profile: "Standard risk by FISH. No TP53 abnormalities."

haem_106:
  morphology: LEUKAEMIA_OTHER
  descriptive_name: Chronic neutrophilic leukemia
  biomarker_profile: "CSF3R T618I mutation detected. JAK2 negative."

haem_107:
  morphology: NON_HODGKIN_LYMPHOMA
  descriptive_name: AIDS-related lymphoma
  biomarker_profile: "MYC rearrangement positive. EBV positive. TP53 disrupted."

haem_108:
  morphology: ACUTE_MYELOID_LEUKAEMIA
  descriptive_name: AML with biallelic CEBPA
  biomarker_profile: "CEBPA double mutant confirmed. NPM1 and FLT3 wild-type."

haem_109:
  morphology: CHRONIC_LYMPHOCYTIC_LEUKAEMIA
  descriptive_name: Monoclonal B-cell lymphocytosis
  biomarker_profile: "Low-level disease. TP53 analysis deferred."

haem_110:
  morphology: NON_HODGKIN_LYMPHOMA
  descriptive_name: Intravascular large B-cell lymphoma
  biomarker_profile: "MYC protein overexpression. TP53 mutation detected."

haem_111:
  morphology: HODGKIN_LYMPHOMA
  descriptive_name: HIV-associated Hodgkin
  biomarker_profile: "EBV-positive. No additional molecular testing."

haem_112:
  morphology: MULTIPLE_MYELOMA
  descriptive_name: Post-transplant myeloma
  biomarker_profile: "Acquired TP53 mutation p.Y163C at relapse."

haem_113:
  morphology: ACUTE_MYELOID_LEUKAEMIA
  descriptive_name: Myeloid sarcoma
  biomarker_profile: "NPM1 mutated. FLT3-ITD negative. Extramedullary presentation."

haem_114:
  morphology: MYELODYSPLASTIC
  descriptive_name: MDS/MPN overlap
  biomarker_profile: "TP53 wild-type. ASXL1 mutation present."

haem_115:
  morphology: CHRONIC_MYELOID_LEUKAEMIA
  descriptive_name: e19a2 CML
  biomarker_profile: "Rare BCR-ABL1 e19a2 transcript detected. Quantification: 32% IS."

haem_116:
  morphology: ACUTE_LYMPHOBLASTIC_LEUKAEMIA
  descriptive_name: TCF3-PBX1 positive ALL
  biomarker_profile: "t(1;19) confirmed. BCR-ABL1 negative. TP53 wild-type."

haem_117:
  morphology: LEUKAEMIA_OTHER
  descriptive_name: LGL leukemia
  biomarker_profile: "STAT3 mutation detected. JAK2 and TP53 negative."

haem_118:
  morphology: NON_HODGKIN_LYMPHOMA
  descriptive_name: Pediatric-type follicular lymphoma
  biomarker_profile: "Lacks BCL2 rearrangement (characteristic). No TP53 mutations."

haem_119:
  morphology: ACUTE_MYELOID_LEUKAEMIA
  descriptive_name: AML-M0
  biomarker_profile: "Minimal differentiation. NPM1 neg, FLT3 neg, TP53 mutation p.R280K."

haem_120:
  morphology: CHRONIC_LYMPHOCYTIC_LEUKAEMIA
  descriptive_name: CLL with trisomy 12
  biomarker_profile: "TP53 intact. NOTCH1 mutation present."

haem_121:
  morphology: MULTIPLE_MYELOMA
  descriptive_name: Non-secretory MM
  biomarker_profile: "Comprehensive FISH: TP53 deletion absent, t(4;14) detected."

haem_122:
  morphology: NON_HODGKIN_LYMPHOMA
  descriptive_name: Plasmablastic lymphoma
  biomarker_profile: "MYC rearranged in 40% of cells. TP53 mutated. HIV-associated."

haem_123:
  morphology: HODGKIN_LYMPHOMA
  descriptive_name: Lymphocyte-depleted HL
  biomarker_profile: "Rare subtype. Molecular studies not performed."

haem_124:
  morphology: ACUTE_MYELOID_LEUKAEMIA
  descriptive_name: AML arising from MDS
  biomarker_profile: "Complex evolution: NPM1 negative, FLT3 negative, TP53 p.R175H (clonal)."

haem_125:
  morphology: MYELODYSPLASTIC
  descriptive_name: 5q- syndrome
  biomarker_profile: "Isolated del(5q). TP53 sequencing: no mutations (good prognosis)."

haem_126:
  morphology: CHRONIC_MYELOID_LEUKAEMIA
  descriptive_name: TKI-resistant CML
  biomarker_profile: "BCR-ABL1 with F317L mutation. BCR-ABL1/ABL1: 8.2% IS."

haem_127:
  morphology: ACUTE_LYMPHOBLASTIC_LEUKAEMIA
  descriptive_name: Near-haploid ALL
  biomarker_profile: "Rare subtype. BCR-ABL1 negative. TP53 alterations common but not detected."

haem_128:
  morphology: LEUKAEMIA_OTHER
  descriptive_name: Juvenile myelomonocytic leukemia
  biomarker_profile: "PTPN11 mutation identified. No JAK2 mutation."

haem_129:
  morphology: NON_HODGKIN_LYMPHOMA
  descriptive_name: ALK+ ALCL
  biomarker_profile: "ALK translocation confirmed. TP53 wild-type. Good prognosis subtype."

haem_130:
  morphology: MULTIPLE_MYELOMA
  descriptive_name: Penta-refractory myeloma
  biomarker_profile: "Multiple high-risk features: TP53 deletion and mutation p.R248Q."

haem_131:
  morphology: ACUTE_MYELOID_LEUKAEMIA
  descriptive_name: Acute megakaryoblastic leukemia
  biomarker_profile: "NPM1 and FLT3 typically negative (confirmed). TP53 wild-type."

haem_132:
  morphology: CHRONIC_LYMPHOCYTIC_LEUKAEMIA
  descriptive_name: Ibrutinib-resistant CLL
  biomarker_profile: "BTK C481S mutation detected. TP53 p.Y234H present."

haem_133:
  morphology: NON_HODGKIN_LYMPHOMA
  descriptive_name: Double-expressor lymphoma
  biomarker_profile: "MYC and BCL2 protein expression >40% and >50% respectively. No translocations. TP53 mutant."

haem_134:
  morphology: HODGKIN_LYMPHOMA
  descriptive_name: Early stage classical HL
  biomarker_profile: "Standard treatment planned. No molecular testing required."

haem_135:
  morphology: ACUTE_MYELOID_LEUKAEMIA
  descriptive_name: AML post-MPN
  biomarker_profile: "JAK2 V617F persists from prior PV. NPM1 negative, FLT3 negative, TP53 p.G245D."

haem_136:
  morphology: MYELODYSPLASTIC
  descriptive_name: Pediatric MDS
  biomarker_profile: "GATA2 deficiency syndrome. TP53 wild-type."

haem_137:
  morphology: CHRONIC_MYELOID_LEUKAEMIA
  descriptive_name: Very early molecular relapse CML
  biomarker_profile: "BCR-ABL1 rising: 0.15% IS (loss of MMR). No mutations detected."

haem_138:
  morphology: ACUTE_LYMPHOBLASTIC_LEUKAEMIA
  descriptive_name: Hypodiploid ALL
  biomarker_profile: "Low hypodiploidy. TP53 germline mutation p.R175H identified."

haem_139:
  morphology: LEUKAEMIA_OTHER
  descriptive_name: Chronic eosinophilic leukemia
  biomarker_profile: "FIP1L1-PDGFRA fusion detected. JAK2 negative."

haem_140:
  morphology: NON_HODGKIN_LYMPHOMA
  descriptive_name: Hepatosplenic T-cell lymphoma
  biomarker_profile: "Isochromosome 7q. TP53 inactivated. Aggressive disease."

haem_141:
  morphology: MULTIPLE_MYELOMA
  descriptive_name: Solitary plasmacytoma
  biomarker_profile: "Limited disease. FISH on marrow: no TP53 or other high-risk features."

haem_142:
  morphology: ACUTE_MYELOID_LEUKAEMIA
  descriptive_name: Blastic plasmacytoid dendritic cell neoplasm
  biomarker_profile: "Rare entity. TET2 mutation present. TP53 intact."

haem_143:
  morphology: CHRONIC_LYMPHOCYTIC_LEUKAEMIA
  descriptive_name: Venetoclax-resistant CLL
  biomarker_profile: "BCL2 G101V mutation acquired. TP53 aberrant (prior)."

haem_144:
  morphology: NON_HODGKIN_LYMPHOMA
  descriptive_name: Enteropathy-associated T-cell lymphoma
  biomarker_profile: "JAK-STAT pathway mutations. TP53 loss frequent - confirmed present."

haem_145:
  morphology: HODGKIN_LYMPHOMA
  descriptive_name: Primary refractory HL
  biomarker_profile: "PD-L1 amplification noted. No other testing performed."

haem_146:
  morphology: ACUTE_MYELOID_LEUKAEMIA
  descriptive_name: Good risk AML
  biomarker_profile: "t(8;21) RUNX1-RUNX1T1 positive. KIT mutation absent (maintains favorable risk)."

haem_147:
  morphology: MYELODYSPLASTIC
  descriptive_name: Refractory anemia
  biomarker_profile: "Low-grade MDS. TP53 and other high-risk mutations absent."

haem_148:
  morphology: CHRONIC_MYELOID_LEUKAEMIA
  descriptive_name: Pregnancy-associated CML
  biomarker_profile: "BCR-ABL1 p210 detected. Baseline 67% IS. Treatment considerations modified."

haem_149:
  morphology: ACUTE_LYMPHOBLASTIC_LEUKAEMIA
  descriptive_name: CAR-T eligible ALL
  biomarker_profile: "CD19 positive B-ALL. BCR-ABL1 negative. Prior TP53 wild-type."

haem_150:
  morphology: LEUKAEMIA_OTHER
  descriptive_name: Atypical CLL
  biomarker_profile: "CD5-negative variant. TP53 disruption absent. JAK2 not relevant."